Reduced Debt In 2025A reduction in debt in 2025 improves near-term solvency and lowers mandatory interest/service obligations, giving management more flexibility to prioritize restructuring or investment. This materially reduces immediate default risk and lengthens runway versus prior years.

Improved Cash Burn In 2025Lower cash burn indicates better cost control or operational adjustments that can extend the firm's financing runway. If sustained, this structural improvement reduces reliance on external funding and supports a path toward breakeven over the medium term.

Intermittent Positive Gross Profit YearsRecurring pockets of gross profitability show the core product mix can generate positive unit economics. That structural ability means if operating expenses are reined in, the business has a plausible route to operating profitability without changing core revenue drivers.

Bears Say

Persistent Net Losses And Negative EquitySustained net losses and chronically negative shareholders’ equity materially weaken long-term solvency and limit strategic options. Negative equity constrains borrowing, increases refinancing risk, and typically forces dilutive capital raises that impede recovery and shareholder value.

Operating And Free Cash Flow Negative Each YearContinuous negative operating and free cash flow imply the business is not self-funding and will remain dependent on external financing. That structural cash deficit raises execution risk, limits reinvestment capacity, and increases vulnerability to capital market access shocks.

Very Small, Volatile And Declining RevenueLow and volatile revenue undermines scalability and margin leverage, making durable profitability unlikely without significant revenue stabilization. Declining top-line in 2025 signals continuing demand or execution issues that structurally hinder growth and recovery prospects.

Biosenta Inc News

Biosenta to Test Antimicrobial Nanoparticles in Alberta Residential Project

The latest update is out from Biosenta Inc ( ($TSE:ZRO) ). Biosenta Inc. has entered into a Field...

2M ago

Biosenta Inc. Strengthens Advisory Board with Industry Veteran

Biosenta Inc ( ($TSE:ZRO) ) has issued an announcement. Biosenta Inc. has announced the addition of Gary LeRoux,...

5M ago

Biosenta’s Tri-Filler™ Achieves 100% Pathogen Elimination in Studies

Biosenta Inc ( ($TSE:ZRO) ) has shared an update. Biosenta Inc. announced that its Tri-Filler™ nanoparticles achieved 100%...

9M ago

Biosenta Inc. Innovates for Eco-Friendly Future

Biosenta Inc (TSE:ZRO) has released an update. Biosenta Inc. has announced notable progress in their bench scale production,...

2y ago

ZRO

Biosenta Inc. Secures Key Licensing Deal

Biosenta Inc (TSE:ZRO) has released an update. Biosenta Inc. has reached a significant milestone by sealing an exclusive...

2y ago

ZRO

Biosenta Inc. Secures $600K in Private Funding

Biosenta Inc (TSE:ZRO) has released an update. Biosenta Inc., a Canadian company specializing in safe and environmentally friendly...

2y ago

ZRO

Biosenta Inc. Launches $600K Private Placement

Biosenta Inc (TSE:ZRO) has released an update. Biosenta Inc. has launched a non-brokered private placement offering aimed at...

2y ago

ZRO

Biosenta Triumphs with Tri-Filler™ Production Milestone

Biosenta Inc (TSE:ZRO) has released an update. Biosenta Inc. has successfully initiated its bench scale production plant, significantly...

2y ago

ZRO

ZRO FAQ

What was Biosenta Inc’s price range in the past 12 months?

Biosenta Inc lowest stock price was C$0.08 and its highest was C$0.17 in the past 12 months.

What is Biosenta Inc’s market cap?

Biosenta Inc’s market cap is C$2.76M.

When is Biosenta Inc’s upcoming earnings report date?

Biosenta Inc’s upcoming earnings report date is Mar 04, 2026 which is in 8 days.

How were Biosenta Inc’s earnings last quarter?

Currently, no data Available

Is Biosenta Inc overvalued?

According to Wall Street analysts Biosenta Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Biosenta Inc pay dividends?

Biosenta Inc does not currently pay dividends.

What is Biosenta Inc’s EPS estimate?

Biosenta Inc’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Biosenta Inc have?

Biosenta Inc has 34,456,387 shares outstanding.

What happened to Biosenta Inc’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Biosenta Inc?

Currently, no hedge funds are holding shares in TSE:ZRO

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Biosenta Inc

Biosenta Inc. develops, manufactures, and sells anti-microbial chemical compounds for household and industrial applications in Canada. It is involved in developing true, an anti-microbial, dual-action disinfectant that kills viruses, bacteria, mold, and germs on contact. The company also intends to manufacture and distribute Tri-Filler, an anti-microbial filler to perform filling and bulking functions. Biosenta Inc. was founded in 1986 and is based in Toronto, Canada.